Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Pharma
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
A small patient population, a wait-and-see attitude and a “fairly significant” infrastructure barrier have slowed CSL's gene therapy rollout.
Angus Liu
Apr 11, 2025 10:32am
Congress's biotech report, NIH ban, GSK-ABL—Fierce Pharma Asia
Apr 11, 2025 10:31am
Rocket boosts preparations for launch with new commercial chief
Apr 8, 2025 11:21am
Sarepta, Roche halt 3 trials in Europe of gene therapy Elevidys
Apr 3, 2025 11:06am
FDA turmoil compounds challenges for cell and gene therapy field
Apr 2, 2025 3:16pm
Bluebird bio receives rival M&A bid worth 50% higher
Mar 28, 2025 7:14pm
